Cargando…
Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis
Immune checkpoint blockade using PD-1 inhibition is an effective approach for treating a wide variety of cancer subtypes. While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported. Here, we present a case of nivolumab-associated autoimm...
Autores principales: | Ferrian, Selena, Liu, Candace C., McCaffrey, Erin F., Kumar, Rashmi, Nowicki, Theodore S., Dawson, David W., Baranski, Alex, Glaspy, John A., Ribas, Antoni, Bendall, Sean C., Angelo, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561237/ https://www.ncbi.nlm.nih.gov/pubmed/34755133 http://dx.doi.org/10.1016/j.xcrm.2021.100419 |
Ejemplares similares
-
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
por: Nguyen, Vina P., et al.
Publicado: (2023) -
Severe Gastritis after Administration of Nivolumab and Ipilimumab
por: Nishimura, Yoshito, et al.
Publicado: (2018) -
Severe Esophagitis and Gastritis from Nivolumab Therapy
por: Boike, Justin, et al.
Publicado: (2017) -
Helicobacter pylori-induced adrenomedullin modulates IFN-γ-producing T-cell responses and contributes to gastritis
por: Kong, Hui, et al.
Publicado: (2020) -
Nivolumab-induced tumour-like gastritis: A case report
por: Cijauskaite, Elena, et al.
Publicado: (2023)